(Q43038559)

12 November 2017

title

Boceprevir for chronic HCV genotype 1 infection (English)

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

12 November 2017

Boceprevir for Chronic HCV Genotype 1 Infection (English)

1 reference

7 December 2024

Jia-Horng Kao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21751913

reference URL

7 December 2024

Ching-Sheng Hsu

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

12 November 2017

14 July 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21751913

reference URL

full work available at URL

7 December 2024

http://www.nejm.org/doi/pdf/10.1056/NEJMc1105515

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

The New England Journal of Medicine

7 December 2024

published in

1 reference

12 November 2017

volume

365

1 reference

12 November 2017

1 reference

12 November 2017

page(s)

176-7; author reply 177-8

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Boceprevir for previously treated chronic HCV genotype 1 infection

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Telaprevir for previously treated chronic HCV infection

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patients.

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Boceprevir for untreated chronic HCV genotype 1 infection

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

Boceprevir for previously treated chronic HCV genotype 1 infection

7 December 2024

1 reference

https://api.crossref.org/works/10.1056/NEJMC1105515

7 December 2024

Identifiers

DOI

10.1056/NEJMC1105515

1 reference

12 November 2017

1 reference